Health/Biotech | New York Citybizlist

Health/Biotech

Intra-Cellular Therapies Closes on $15.3 Million
Posted on May 20, 2013
Stemline Therapeutics Prices $60 Million Offering
Posted on May 17, 2013
Orgenesis Raises $1.3 Million
Posted on May 17, 2013
Rib-X Pharmaceuticals Appoints John E. Sununu to the Board of Directors
Posted on May 13, 2013
NeoStem CEO's Letter to Shareholders
Posted on May 10, 2013
Aetna Completes Acquisition of Coventry Health Care
Posted on May 7, 2013
Health Media Network Acquires Care Media Holdings
Posted on May 7, 2013
How Regeneron's Eylea Became A 'Trump Card' In The Niche AMD Market
Posted on May 6, 2013
NeoStem Closes 23M Shares Offering
Posted on May 5, 2013
Aetna to Complete Acquisition of Coventry Health Care
Posted on May 3, 2013
KannaLife Sciences Closes on $1.5 Million
Posted on May 1, 2013
Celsus Therapeutics Appoints Fredric Price to Board
Posted on April 30, 2013
AccentHealth Announces New Leadership for its Medical Advisory Board
Posted on April 23, 2013
Ohr Pharmaceutical Announces $5 Million Financing from Exercise of Warrants
Posted on April 22, 2013
BioScrip Prices Underwritten Offering of Common Stock
Posted on April 19, 2013
Henry Schein Secures $300 Million Of Committed Financing
Posted on April 19, 2013
BioScrip Announces Public Offering of Common Stock
Posted on April 16, 2013
Islet Sciences Issues Shareholder Update Letter
Posted on April 16, 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Posted on April 15, 2013
Anterios Raises $4.7 Million
Posted on April 11, 2013

Pages